Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Patent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons.

Waleh N, McCurnin DC, Yoder BA, Shaul PW, Clyman RI.

Pediatr Res. 2011 Mar;69(3):212-6. doi: 10.1203/PDR.0b013e3182084f8d.

2.

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

Ohlsson A, Walia R, Shah S.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003481. doi: 10.1002/14651858.CD003481.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD003481.

PMID:
18254020
3.

Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.

Malviya M, Ohlsson A, Shah S.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003951. doi: 10.1002/14651858.CD003951.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD003951.

PMID:
18254035
4.

The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.

Clyman RI.

Semin Perinatol. 2013 Apr;37(2):102-7. doi: 10.1053/j.semperi.2013.01.006. Review.

5.
6.

Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.

Ohlsson A, Walia R, Shah S.

Cochrane Database Syst Rev. 2003;(2):CD003481. Review. Update in: Cochrane Database Syst Rev. 2005;(4):CD003481.

PMID:
12804469
7.
8.

Therapeutic closure of the ductus arteriosus: benefits and limitations.

Mercanti I, Boubred F, Simeoni U.

J Matern Fetal Neonatal Med. 2009;22 Suppl 3:14-20. doi: 10.1080/14767050903198132. Review.

PMID:
19925358
9.
10.

Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Shah SS, Ohlsson A.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004213. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD004213.

PMID:
16437478
11.
12.

Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.

Malviya MN, Ohlsson A, Shah SS.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD003951. doi: 10.1002/14651858.CD003951.pub3. Review.

PMID:
23543527
13.

Patent ductus arteriosus in preterm neonates.

Aggarwal R, Bajpai A, Deorari AK, Paul VK.

Indian J Pediatr. 2001 Oct;68(10):981-4. Review.

PMID:
11758138
14.

[Ibuprofen versus indomethacin in the preterm persistent patent ductus arteriosus therapy: review and meta-analysis].

Gimeno Navarro A, Modesto Alapont V, Morcillo Sopena F, Fernández Gilino C, Izquierdo Macián I, Gutiérrez Laso A.

An Pediatr (Barc). 2007 Oct;67(4):309-18. Review. Spanish.

15.

A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus.

Thomas RL, Parker GC, Van Overmeire B, Aranda JV.

Eur J Pediatr. 2005 Mar;164(3):135-40. Epub 2004 Dec 10. Review.

PMID:
15717178
16.

Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants.

Gouyon JB, Kibleur Y.

Clin Ther. 2010 Sep;32(10):1740-8. doi: 10.1016/j.clinthera.2010.08.011. Review.

PMID:
21194597
17.

Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Ohlsson A, Shah SS.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD004213. doi: 10.1002/14651858.CD004213.pub3. Review.

PMID:
21735396
18.

Treatment of patent ductus arteriosus: indomethacin or ibuprofen?

Sekar KC, Corff KE.

J Perinatol. 2008 May;28 Suppl 1:S60-2. doi: 10.1038/jp.2008.52. Review.

PMID:
18446180
19.

Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants.

Mosalli R, Alfaleh K.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006181. doi: 10.1002/14651858.CD006181.pub2. Review.

PMID:
18254095
20.

Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.

Ohlsson A, Walia R, Shah SS.

Cochrane Database Syst Rev. 2015 Feb 18;(2):CD003481. doi: 10.1002/14651858.CD003481.pub6. Review.

PMID:
25692606

Supplemental Content

Support Center